Eberconazole
CAS: 128326-82-9
Ref. 3D-DFA32682
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
- 1-(2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-1H-imidazole
- 1H-Imidazole, 1-(2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-
Eberconazole is an analog of a protein kinase inhibitor that has been shown to have anticancer properties. It is used in the treatment of various types of cancer and tumors in humans. Eberconazole works by inhibiting cyclin-dependent kinases, which are enzymes involved in cell division and growth. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. Eberconazole has been found to be effective against Chinese hamster ovary (CHO) cells and has shown promise as a potential anticancer drug. It is excreted primarily through urine after administration.
Propriedades químicas
Consulta técnica sobre: 3D-DFA32682 Eberconazole
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
